Sleepio has become the first digital therapeutic to receive NICE guidelines

The National Institute for Health and Care Excellence (NICE) recommends the Sleepio app as an effective alternative to sleeping pills.

Under his guidance, the NICE app created the digital therapeutics (DTx) firm Great healthA safe and effective treatment for people suffering from insomnia.

It adds that the app can save NHS money and reduce prescriptions for drugs like Zolpidem and Jopiclone. Dependence may form.

The Sleepio app provides people with digital cognitive behavioral therapy (CBT-I) suitable for insomnia using an artificial intelligence (AI) algorithm.

Why it matters

Studies show that around one-third of adults in the UK experience insomnia symptoms each week. NICE recommends CBT-I as a first-line treatment for insomnia, given before or along with medication. However, due to the lack of trained therapists, CBT-I is not regularly available on the NHS for most people who live with insomnia.

Clinical evidence presented to NICE’s Medical Technology Advisory Committee from 12 randomized controlled trials has shown that sleep is more effective in reducing insomnia than sleep hygiene and sleeping pills.

Greater context

Since October last year, Adults in Scotland Anxiety has been able to access both the Sleepio app and the Big Health DTX app. Daylight.

A Research published last year It has been found that sleep, anxiety, and depression are more likely to be caused by sleep deprivation than by any other psychological intervention.

Meanwhile DTX course in Germany Halobetter stress and burnout Recently approved by the Federal Institute for Drugs and Medical Devices (BfArM) for the treatment of stress, fatigue, insomnia and depression.

On the record

Janet Kussell, Acting Director of Med Tech & Digital, NICE, said: “Our rigorous, transparent and evidence-based analysis shows that Slipio is cost-effective for the NHS compared to normal treatment in primary care. This will reduce the insomnia’s dependence on over-the-counter drugs such as Zolpidem and Jopiclone.

“This is a good example of where a digital health technology can help the NHS. Evidence has shown that using Slipio reduces the number of GP appointments needed by insomnia patients and also reduces the number of prescriptions for sleeping pills distributed by pharmacists.”

Colin Esp, co-founder of Big Health and chief science professor, said: “With the growing demand for mental health care over the past two years, measurable and clinically proven digital technologies must be part of the solution. Positive results through NICE guidance Helps reduce NHS care backlogs and provides secure, evidence-based, accessible support for everyone in need. “

Dr Nick Brownton, CEO of the Oxford Health NHS Foundation Trust and a board member of the Oxford Academic Health and Science Network (AHSN), said: Slipio has the potential to transform existing mental health pathways by expanding access to guideline-proposed care for everyone in England. “

Leave a Reply

Your email address will not be published.